Fall cohort includes companies specializing in advanced materials, therapeutics, and clean technology.
Wilmington, Delaware — The Innovation Space™ today announced that it has accepted 11 companies, for its Fall 2023 Science Inc.™ Accelerator Program, a virtual, cohort-based accelerator for early-stage science-based startups. With the support of expert coaches (Entrepreneurs-in-Residence), Science Inc.™ participants will work toward major milestones to quickly and successfully ramp up their businesses.
Science Inc.™ gives companies access to industry and investment experts who can advise participants on decision-making in the critical early stages of their development. Through the connections with experts and their cohort, participants cultivate a network of potential investors and collaborator partners.
Eligible participating startups also have an opportunity to apply for up to an additional $200,000 in support through the First Fund™ investment program.
“We’re excited by the growth potential in all members of this cohort,” said Bill Provine, Innovation Space founder and CEO. “From repurposing food waste to developing medicines and technologies that will improve health outcomes, these startups are creating new solutions to some of world’s most important and pressing needs. Our role at The Innovation Space and through our Science Inc. accelerator program is to help these startups magnify their impact and speed their trajectory to market.”
Companies participating in the Fall 2023 cohort include:
Cyta Therapeutics is developing a therapeutic to treat obesity and associated cardiometabolic diseases.
Edulis Therapeutics is developing a minimally-invasive bioresorbable implant for localized drug delivery in patients with inflammatory bowel disease (IBD).
EndoShunt is a developing medical device that aims to end preventable deaths from abdominal bleeding by giving trauma surgeons the gift of time so they can give trauma patients the gift of life.
Foogly is a cleantech startup that uses food waste to make bioplastics and biopolymers through a one-step, eco-friendly process.
Graftable is developing oxygen microspheres to improve graft survival after reconstructive surgery.
Margik is the world’s first low-cost high-volume Organic LED platform that is enabling automotive lighting to become efficient and sustainable.
NKA Bio is developing therapeutic, temperature stable antibodies for critical care.
PriZm is a clinical-stage pediatric rare disease company developing a platform that comprises small molecule, oral therapy for treating MCT8 deficiency in pre- and post-natal babies.
RecurX has developed a microfluidic based diagnostic technology platform that informs the seriousness of the disease, the standard of care needed, and drug treatment options.
Serentrix is developing non-addictive medicine for pain management.
Sindri Materials is an advanced materials company committed to bringing the absolute highest quality graphene into the highest impact applications through novel and proprietary manufacturing methods.
To date and including the current cohort, Science Inc.™ has supported 61 startup participants from 15 states and four countries, including the U.S.
“The Innovation Space entrepreneurs-in-residence are fantastic, and extremely experienced in all aspects of startup management,” said Jason Winder, CEO of Sonogen Medical, a Science Inc. alumni company. “They helped me improve my pitch deck, enhance my financials, and refine my fundraising strategy in ways that I never would have expected.”
The Science Inc.™ Accelerator program accepts companies twice per year, in the fall and spring. The selective program receives applications from across the United States and beyond, with special consideration given to startups who are located or interested in locating within the Mid-Atlantic region.
Eligible industries include: aerospace, agriculture, biotechnology, chemicals and chemical products, therapeutics, diagnostics, clean technology, electronics/instrumentation, food and beverage, healthcare services, industrial/energy, marine and blue technology, medical devices and equipment, nanotechnology, oil and gas, renewables/renewable energy, semiconductors, telecommunications, therapeutics, and transportation.
Science Inc.™ is among a suite of Innovation Space programs funded by a $1.5 million U.S. Department of Commerce grant, which is designed to build regional economies by supporting the growth of technology-oriented startups.
About The Innovation Space™:
The Innovation Space™ is a not-for-profit innovation ecosystem and is a virtual and physical home for leading science entrepreneurs. The Innovation Space™ works to “transform science and technology startups into industry leading companies.” Located on the historic Experimental Station campus in Wilmington, Delaware, The Innovation Space™ is comprised of 130,000 ft2 of state-of-the-art lab and office space with access to cutting edge equipment alongside a suite of entrepreneurship programs and opportunities supporting startup growth. Register for more information and updates to learn more about all The Innovation Space™ programs and funding opportunities.